# CPHI (China Pharma Holdings, Inc.) - SEC EDGAR Financial Statements

> China Pharma Holdings, Inc. reported $4.31M in revenue and a net loss of $5.73M for the trailing twelve months ended September 30, 2026 (up 52.5% year over year), with a 14.2% gross margin and a -130.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/CPHI
- Markdown: https://convexityos.com/fundamentals/CPHI.md
- SEC CIK: 0001106644
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001106644&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $4.31M | +52.5% YoY |
| Operating Income | TTM | -$5.63M | -130.5% margin |
| Net Income | TTM | -$5.73M | -132.8% net margin |
| Diluted EPS | TTM | -$0.13 | Split-adjusted |
| Free Cash Flow | TTM | $89K | 2.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $3.68M | Total debt: $1.70M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.14M | $4.53M | $7.01M | $8.10M | $9.64M | $10.87M | $10.92M | $12.33M | $13.21M | $15.57M |
| Cost of Revenue | $4.28M | $6.51M | $7.29M | $8.60M | $9.29M | $8.91M | $9.44M | $10.36M | $10.74M | $12.35M |
| **Gross Profit** | -$132K | -$1.99M | -$281K | -$494K | $349K | $1.95M | $1.48M | $1.97M | $2.47M | $3.22M |
| Research & Development | $281K | $284K | $240K | $186K | $319K | $378K | $230K | $172K | $90K | $366K |
| Selling, General & Admin | $2.83M | $2.31M | $2.25M | $2.96M | $3.15M | $4.04M | $4.64M | $5.17M | $5.48M | $6.30M |
| Total Operating Expenses | $3.11M | $2.60M | $2.47M | $3.06M | $3.21M | $4.53M | $21.89M | $12.42M | $21.15M | $11.72M |
| **Operating Income** | -$3.24M | -$4.59M | -$2.75M | -$3.55M | -$2.86M | -$2.58M | -$20.41M | -$10.45M | -$18.68M | -$8.16M |
| **EBITDA** | -$1.74M | -$1.97M | $1.8K | -$848K | $227K | $101K | -$17.48M | -$7.19M | -$15.39M | -$5.08M |
| Interest Income | $2.0K | $6.6K | $6.6K | $11K | $3.0K | $5.7K | $28K | $39K | $64K | $131K |
| Interest Expense | $27K | $27K | $31K | $435K | $542K | $294K | $322K | $451K | $539K | $850K |
| Income Before Tax | -$3.19M | -$4.74M | -$3.08M | -$3.97M | -$3.40M | -$2.87M | -$20.70M | -$10.86M | -$19.15M | -$8.87M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | -$110K | $123K | $308K |
| **Net Income** | -$3.19M | -$4.74M | -$3.08M | -$3.97M | -$3.40M | -$2.87M | -$20.70M | -$10.75M | -$19.28M | -$9.18M |
| Basic EPS | -$0.74 | -$2.71 | -$9.10 | -$1,208.23 | -$11,826.59 | -$1,118.73 | -$7,671.30 | -$3,995.47 | -$7,032.03 | -$3,356.19 |
| **Diluted EPS** | -$0.74 | -$2.71 | -$9.10 | -$1,208.23 | -$11,826.59 | -$1,118.73 | -$7,671.30 | -$3,995.47 | -$7,032.03 | -$3,356.19 |
| Basic Shares Outstanding | 4.3M | 1.7M | 338.4K | 3.3K | 289 | 2.7K | 2.7K | 2.7K | 2.7K | 2.7K |
| Diluted Shares Outstanding | -- | -- | -- | -- | 2.9K | 2.7K | 2.7K | 2.7K | 2.7K | 2.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.15M | $948K | $984K | $1.23M | $756K | $1.03M | $1.14M | $1.13M |
| Cost of Revenue | $1.06M | $865K | $698K | $1.08M | $816K | $1.11M | $1.27M | $1.29M |
| **Gross Profit** | $92K | $84K | $285K | $151K | -$60K | -$87K | -$136K | -$161K |
| Research & Development | $16K | $19K | $84K | $190K | $40K | $21K | $30K | $547 |
| Selling, General & Admin | $1.45M | $1.49M | $1.32M | $1.19M | $503K | $542K | $594K | $1.03M |
| Total Operating Expenses | $1.97M | $1.52M | $1.40M | $1.35M | $568K | $565K | $623K | $1.04M |
| **Operating Income** | -$1.88M | -$1.43M | -$1.12M | -$1.20M | -$628K | -$652K | -$759K | -$1.20M |
| **EBITDA** | -$753K | -$330K | -$137K | -$703K | -$272K | -$331K | -$429K | -$748K |
| Interest Income | $2.2K | $81 | $147 | $213 | $294 | $422 | $1.1K | $1.3K |
| Interest Expense | $10K | $9.3K | $9.1K | $6.9K | $6.8K | $6.8K | $6.8K | $6.8K |
| Income Before Tax | -$1.90M | -$1.46M | -$1.14M | -$1.22M | -$651K | -$528K | -$786K | -$1.22M |
| **Net Income** | -$1.90M | -$1.46M | -$1.14M | -$1.22M | -$651K | -$528K | -$786K | -$1.22M |
| Basic EPS | -$0.04 | -$0.04 | -$0.04 | -- | -$0.17 | -$0.16 | -$0.24 | -- |
| **Diluted EPS** | -$0.04 | -$0.04 | -$0.04 | -- | -$0.17 | -$0.16 | -$0.24 | -- |
| Basic Shares Outstanding | 42.4M | 40.5M | 25.6M | -- | 3.9M | 3.2M | 3.3M | -- |
| Diluted Shares Outstanding | 42.4M | 40.5M | 25.6M | -- | 3.9M | 3.2M | 3.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $345K | $627K | $1.42M | $2.03M | $4.86M | $958K | $1.07M | $1.19M | $2.03M | $2.67M |
| **Cash & Short-Term Investments** | $345K | $627K | $1.42M | $2.03M | $4.86M | $958K | $1.07M | $1.19M | $2.03M | $2.67M |
| Accounts Receivable, Net | $241K | $232K | $504K | $422K | -- | $502K | $635K | $917K | $2.29M | $4.00M |
| Inventory | $1.62M | $2.27M | $3.73M | $2.95M | $2.95M | $3.71M | $3.59M | $5.05M | $6.41M | $7.31M |
| **Total Current Assets** | $2.35M | $3.27M | $6.00M | $5.96M | $9.09M | $5.32M | $5.58M | $8.75M | $12.29M | $17.52M |
| Property, Plant & Equipment, Net | $4.39M | $4.88M | $7.10M | $9.97M | $13.28M | $15.56M | $16.31M | $19.29M | $23.54M | $24.97M |
| Intangible Assets | $24.08M | $6.70M | $3.26M | $1.81M | $148K | $182K | $206K | $266K | $399K | $535K |
| **Total Non-Current Assets** | $28.65M | $11.62M | $10.47M | $11.82M | $13.56M | $15.80M | $16.66M | $36.63M | $47.66M | $61.00M |
| **Total Assets** | $31.00M | $14.89M | $16.47M | $17.78M | $22.65M | $21.12M | $22.24M | $45.38M | $59.95M | $78.52M |
| Accounts Payable | $891K | $225K | $966K | $667K | $927K | $1.23M | $1.37M | $1.06M | $1.14M | $3.06M |
| Short-Term Debt | $1.44M | $1.14M | $1.13M | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $112K | $162K | $91K | $520K | $210K | $720K | $505K | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $2.48M | $2.78M | $2.13M | $2.07M | -- | -- | -- |
| **Total Current Liabilities** | $7.40M | $5.02M | $6.82M | $12.74M | $10.51M | $11.40M | $10.05M | $10.05M | $9.23M | $10.40M |
| Long-Term Debt | -- | -- | -- | -- | -- | $5.24M | $4.30M | $6.54M | $9.22M | -- |
| **Total Non-Current Liabilities** | $859K | $2.12M | $2.19M | $755K | $6.12M | $1.71M | $2.95M | $5.13M | $7.65M | $9.21M |
| **Total Liabilities** | $8.26M | $7.14M | $9.01M | $13.49M | $16.63M | $13.11M | $13.00M | $15.18M | $16.88M | $19.61M |
| **Total Debt (incl. Leases)** | $1.62M | $1.18M | $1.25M | $40K | $85K | $5.29M | $4.44M | $6.54M | $9.22M | -- |
| Common Stock | $16K | $3.3K | $11K | $1.5K | $47K | $46K | $44K | $44K | $44K | $44K |
| Retained Earnings | -$47.21M | -$44.03M | -$39.29M | -$36.21M | -$32.24M | -$28.84M | -$25.97M | -$5.27M | $5.48M | $24.76M |
| Accumulated Other Comp. Income | $11.58M | $11.32M | $11.45M | $11.57M | $12.56M | $12.35M | $11.58M | $11.84M | $13.96M | $10.52M |
| **Total Stockholders' Equity** | $22.74M | $7.75M | $7.45M | $4.29M | $6.02M | $8.00M | $9.24M | $30.20M | $43.07M | $58.91M |
| Total Equity | $22.74M | $7.75M | $7.45M | $4.29M | $6.02M | $8.00M | $9.24M | $30.20M | $43.07M | $58.91M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.68M | $305K | $168K | $345K | $268K | $600K | $400K | $627K |
| **Cash & Short-Term Investments** | $3.68M | $305K | $168K | $345K | $268K | $600K | $400K | $627K |
| Accounts Receivable, Net | $197K | $182K | $196K | $241K | $225K | $269K | $329K | $232K |
| Inventory | $1.32M | $1.36M | $1.50M | $1.62M | $1.65M | $1.68M | $1.98M | $2.27M |
| **Total Current Assets** | $5.39M | $2.01M | $2.00M | $2.35M | $2.33M | $2.70M | $2.85M | $3.27M |
| Property, Plant & Equipment, Net | $4.12M | $4.22M | $4.30M | $4.39M | $4.50M | $4.63M | $4.78M | $4.88M |
| Intangible Assets | $37.30M | $38.34M | $38.67M | $24.08M | $8.78M | $6.44M | $6.57M | $6.70M |
| **Total Non-Current Assets** | $41.54M | $42.70M | $43.14M | $28.65M | $13.48M | $11.07M | $11.37M | $11.62M |
| **Total Assets** | $46.93M | $44.71M | $45.14M | $31.00M | $15.80M | $13.77M | $14.22M | $14.89M |
| Accounts Payable | $304K | $734K | $837K | $891K | $589K | $531K | $548K | $225K |
| Short-Term Debt | $1.57M | $1.64M | $1.47M | $1.44M | $1.41M | $1.41M | $1.15M | $1.14M |
| Deferred Revenue (Current) | $48K | $154K | $62K | $112K | $121K | $78K | $114K | $162K |
| **Total Current Liabilities** | $7.03M | $7.68M | $7.27M | $7.40M | $6.62M | $5.25M | $5.12M | $5.02M |
| **Total Non-Current Liabilities** | $838K | $847K | $852K | $859K | $868K | $2.05M | $2.13M | $2.12M |
| **Total Liabilities** | $7.86M | $8.53M | $8.12M | $8.26M | $7.49M | $7.30M | $7.25M | $7.14M |
| **Total Debt (incl. Leases)** | $1.70M | $1.79M | $1.63M | $1.62M | $1.61M | $1.41M | $1.17M | $1.18M |
| Common Stock | $43K | $41K | $41K | $16K | $5.0K | $3.3K | $3.3K | $3.3K |
| Retained Earnings | -$51.72M | -$49.82M | -$48.36M | -$47.21M | -$45.99M | -$45.34M | -$44.81M | -$44.03M |
| Accumulated Other Comp. Income | $13.04M | $12.63M | $12.02M | $11.58M | $11.40M | $11.35M | $11.33M | $11.32M |
| **Total Stockholders' Equity** | $39.07M | $36.18M | $37.02M | $22.74M | $8.31M | $6.46M | $6.97M | $7.75M |
| Total Equity | $39.07M | $36.18M | $37.02M | $22.74M | $8.31M | $6.46M | $6.97M | $7.75M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.19M | -$4.74M | -$3.08M | -$3.97M | -$3.40M | -$2.87M | -$20.70M | -$10.75M | -$19.28M | -$9.18M |
| Depreciation & Amortization | $1.50M | $2.62M | $2.75M | $2.70M | $3.09M | $2.68M | $2.93M | $3.26M | $3.29M | $3.08M |
| Change in Receivables | -$13.88M | $0 | $0 | $0 | $0 | -$688K | $0 | $0 | $0 | -$13.50M |
| Change in Inventory | $590K | $1.61M | -$17K | $689K | $1.01M | $808K | $2.00M | $689K | $1.72M | $2.73M |
| Change in Payables | $650K | -$734K | $312K | -$188K | -$333K | -$214K | $324K | -$16K | -$2.05M | $815K |
| **Operating Cash Flow** | $148K | -$406K | -$700K | -$410K | -$250K | -$42K | $608K | $1.88M | $841K | $2.90M |
| Capital Expenditure | -$59K | -$38K | -$12K | -$402K | -$438K | -$867K | -$136K | -$51K | -$136K | -$193K |
| **Free Cash Flow** | $89K | -$444K | -$711K | -$812K | -$688K | -$910K | $472K | $1.83M | $705K | $2.70M |
| **Investing Cash Flow** | -$137K | -$292K | -$12K | -$402K | -$438K | -$867K | -$136K | -$51K | -$136K | -$193K |
| **Financing Cash Flow** | -$294K | -$34K | $73K | -$1.77M | $4.60M | $624K | -$1.73M | -$1.98M | -$1.48M | -$6.02M |
| **Net Change in Cash** | -$282K | -$797K | -$606K | -$2.83M | $3.90M | -$227K | -$1.28M | -$279K | -$636K | -$3.58M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.90M | -$1.46M | -$1.14M | -$1.22M | -$651K | -$528K | -$786K | -$1.22M |
| Depreciation & Amortization | $1.12M | $1.10M | $981K | $497K | $356K | $321K | $329K | $448K |
| Stock-Based Compensation | -- | $0 | $0 | -- | -- | $0 | -- | -- |
| Change in Inventory | $17K | $273K | $247K | $211K | $58K | $165K | $157K | $511K |
| Change in Payables | -$431K | -$116K | -$68K | $292K | $54K | -$19K | $323K | -$156K |
| **Operating Cash Flow** | -$1.11M | -$33K | -$55K | $152K | -$204K | $274K | -$74K | $299K |
| Capital Expenditure | -- | -- | -- | -$454 | -$611 | $65 | -$58K | -- |
| **Free Cash Flow** | -- | -- | -- | $152K | -$205K | $274K | -$132K | -- |
| **Investing Cash Flow** | -- | -- | -- | -$5.8K | -$73K | $65 | -$58K | -- |
| **Financing Cash Flow** | $4.50M | $120K | -$79K | -$73K | -$122K | -$22K | -$77K | -$54K |
| **Net Change in Cash** | $3.38M | $136K | -$177K | $77K | -$357K | $212K | -$214K | -$92K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -3.2% | -43.8% | -4.0% | -6.1% | 3.6% | 18.0% | 13.6% | 16.0% | 18.7% | 20.7% |
| **Operating Margin** | -78.2% | -101.3% | -39.2% | -43.8% | -29.7% | -23.7% | -186.8% | -84.7% | -141.4% | -52.4% |
| **Net Profit Margin** | -76.9% | -104.6% | -43.9% | -49.0% | -35.3% | -26.4% | -189.5% | -87.2% | -145.9% | -59.0% |
| Return on Equity (ROE) | -14.0% | -61.1% | -41.3% | -92.6% | -56.5% | -35.8% | -224.1% | -35.6% | -44.8% | -15.6% |
| Return on Assets (ROA) | -10.3% | -31.8% | -18.7% | -22.3% | -15.0% | -13.6% | -93.1% | -23.7% | -32.2% | -11.7% |
| Current Ratio | 0.32x | 0.65x | 0.88x | 0.47x | 0.86x | 0.47x | 0.56x | 0.87x | 1.33x | 1.68x |
| Quick Ratio | 0.10x | 0.20x | 0.33x | 0.24x | 0.58x | 0.14x | 0.20x | 0.37x | 0.64x | 0.98x |
| Debt to Equity | 0.07x | 0.15x | 0.17x | 0.01x | 0.01x | 0.66x | 0.48x | 0.22x | 0.21x | -- |
| **Revenue Growth (YoY)** | -8.5% | -35.4% | -13.5% | -15.9% | -11.3% | -0.5% | -11.4% | -6.7% | -15.1% | -23.5% |
| Gross Profit Growth (YoY) | -- | -- | -- | -241.4% | -82.1% | +31.8% | -24.9% | -20.0% | -23.3% | +119.8% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -106.9% | -67.7% | +123.7% | -70.9% | -13.6% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -292.6% | -74.2% | +159.8% | -73.9% | -33.0% |
| 5Y Revenue / Share Growth | -100.0% | -99.9% | -99.5% | -49.1% | +484.3% | -46.7% | -50.6% | -- | -- | -- |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 14.2% | 11.8% | 7.3% | -3.2% | -10.9% | -20.5% | -42.6% | -43.8% |
| **Operating Margin** | -130.5% | -111.8% | -90.1% | -78.2% | -79.8% | -84.0% | -103.2% | -101.3% |
| **Net Profit Margin** | -132.8% | -114.3% | -88.8% | -76.9% | -78.7% | -83.2% | -106.3% | -104.6% |
| Return on Equity (ROE) | -14.7% | -12.4% | -9.6% | -14.0% | -38.4% | -56.6% | -65.5% | -61.1% |
| Return on Assets (ROA) | -12.2% | -10.0% | -7.9% | -10.3% | -20.2% | -26.6% | -32.1% | -31.8% |
| Current Ratio | 0.77x | 0.26x | 0.28x | 0.32x | 0.35x | 0.51x | 0.56x | 0.65x |
| Quick Ratio | 0.58x | 0.08x | 0.07x | 0.10x | 0.10x | 0.19x | 0.17x | 0.20x |
| Debt to Equity | 0.04x | 0.05x | 0.04x | 0.07x | 0.19x | 0.22x | 0.17x | 0.15x |
| **Revenue Growth (YoY)** | +52.5% | -7.5% | -13.4% | +8.1% | -31.3% | +10.9% | -17.0% | -47.2% |
| Operating Cash Flow Growth (YoY) | -- | -112.0% | -- | -49.1% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
